Reuters logo
MDL sought for cases linking Taxotere to permanent hair loss
July 27, 2016 / 10:56 AM / a year ago

MDL sought for cases linking Taxotere to permanent hair loss

Plaintiffs’ lawyers have requested a new multidistrict litigation for lawsuits alleging that Sanofi SA’s chemotherapy drug Taxotere can cause permanent hair loss in women, particularly those being treated for breast cancer.

In a July 22 motion, lawyers for two plaintiffs asked the U.S. Judicial Panel on Multidistrict Litigation to send Taxotere litigation - currently comprising 33 lawsuits in 16 federal courts - to the U.S. District Court for the Eastern District of Louisiana.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2aJJDCH

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below